Also known as: Biolimus A9; TRM-986
Umirolimus (Biolimus) is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.
Umirolimus (Biolimus A9) is a semi-synthetic macrolide immunosuppressant and mTOR inhibitor used in drug-eluting coronary stents to prevent restenosis. Its highly lipophilic nature allows rapid uptake by vascular smooth muscle cells, suppressing proliferation.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No. | TPF/24033039 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |